2016-03-12T00:00:00.000-05:00
Pfizer Inc.,-0.242333
abnormal cells,-0.661371
lung cancer,-0.408861
treatment,-0.242333
Xalkori,-0.242333
non-small cell lung,-0.575388
tumors,-0.575388
advanced non-small-cell lung,-0.242333
ROS-1 gene alteration,-0.575388
rare form,-0.242333
Friday,-0.242333
Drug Administration,-0.242333
U.S. Food,-0.242333
